diethylcarbamazine has been researched along with Eye Disorders in 53 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The ocular changes that occur with diethylcarbamazine treatment of onchocerciasis seriously restrict its usefulness." | 9.06 | Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine. ( Aziz, MA; Cupp, EW; D'Anna, SA; Greene, BM; Keyvan-Larijani, E; Murphy, RP; Newland, HS; Taylor, HR; White, AT, 1986) |
| "In a randomised double-blind study, ivermectin was compared with diethylcarbamazine (DEC) and placebo in the treatment of onchocerciasis in 30 male patients from Mali with moderate to heavy Onchocerca volvulus infections and ocular involvement." | 9.05 | Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. ( Aziz, M; Basset, D; Beauvais, B; Derouin, F; Gaxotte, P; Ginoux, J; Lariviere, M; Schulz-Key, H; Vingtain, P; Weimann, D, 1985) |
| "We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial." | 9.05 | Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985) |
| "The response of 45 severely infected onchocerciasis patients to relatively high doses of diethylcarbamazine citrate (DEC-C) has been determined." | 7.67 | The Onchocerca volvulus micro- and macrofilarial responses in onchocerciasis patients to increased dosage of diethylcarbamazine. ( Beltranena, F; Langham, ME, 1985) |
| "Eighteen patients, moderately to heavily infected with onchocerciasis, were treated with a standard course of diethylcarbamazine citrate (DEC-C)." | 7.66 | Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. ( Anderson, J; Bird, AC; el-Sheikh, H; Fuglsang, H, 1980) |
| "A single 10-14 day course of diethylcarbamazine (DEC) was given under betamethazone cover to 18 patients (Group A) with ocular onchocerciasis, and the effects were studied in detail over 1-2 years." | 7.65 | Effects of diethylcarbamazine on ocular onchocerciasis. ( Anderson, J; de C Marshall, TF; Fuglsang, H, 1976) |
| " Clinical adverse reactions were recorded in four ivermectin, ten DEC and three placebo patients." | 6.66 | A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. ( Aziz, MA; Badiane, S; Diallo, JS; Diallo, S; Diop-Mar, I; Gaxotte, P; Lariviere, M; N'Dir, O; Py, D; Schulz-Key, H, 1986) |
| "Diethylcarbamazine was given as eye drops in varying concentrations in a half-log dilution series from 1." | 5.26 | Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery. ( Anderson, J; Fuglsang, H; Jones, BR, 1978) |
| "The ocular changes that occur with diethylcarbamazine treatment of onchocerciasis seriously restrict its usefulness." | 5.06 | Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine. ( Aziz, MA; Cupp, EW; D'Anna, SA; Greene, BM; Keyvan-Larijani, E; Murphy, RP; Newland, HS; Taylor, HR; White, AT, 1986) |
| "In a randomised double-blind study, ivermectin was compared with diethylcarbamazine (DEC) and placebo in the treatment of onchocerciasis in 30 male patients from Mali with moderate to heavy Onchocerca volvulus infections and ocular involvement." | 5.05 | Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. ( Aziz, M; Basset, D; Beauvais, B; Derouin, F; Gaxotte, P; Ginoux, J; Lariviere, M; Schulz-Key, H; Vingtain, P; Weimann, D, 1985) |
| "We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial." | 5.05 | Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. ( Aziz, MA; Cupp, EW; D'Anna, SA; Goldschmidt, LP; Greene, BM; Murphy, RP; Newland, HS; Schulz-Key, H; Taylor, HR; White, AT, 1985) |
| "The response of 45 severely infected onchocerciasis patients to relatively high doses of diethylcarbamazine citrate (DEC-C) has been determined." | 3.67 | The Onchocerca volvulus micro- and macrofilarial responses in onchocerciasis patients to increased dosage of diethylcarbamazine. ( Beltranena, F; Langham, ME, 1985) |
| "Eighteen patients, moderately to heavily infected with onchocerciasis, were treated with a standard course of diethylcarbamazine citrate (DEC-C)." | 3.66 | Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. ( Anderson, J; Bird, AC; el-Sheikh, H; Fuglsang, H, 1980) |
| "Recurrent skin edemata due to an infestation with the filaria Loa loa are called Cameroon or Calabar swellings." | 3.66 | [Cameroon swelling; infection by the filaria Loa loa]. ( Gewalt, W; Grüntzig, J, 1979) |
| "A single 10-14 day course of diethylcarbamazine (DEC) was given under betamethazone cover to 18 patients (Group A) with ocular onchocerciasis, and the effects were studied in detail over 1-2 years." | 3.65 | Effects of diethylcarbamazine on ocular onchocerciasis. ( Anderson, J; de C Marshall, TF; Fuglsang, H, 1976) |
| " Clinical adverse reactions were recorded in four ivermectin, ten DEC and three placebo patients." | 2.66 | A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. ( Aziz, MA; Badiane, S; Diallo, JS; Diallo, S; Diop-Mar, I; Gaxotte, P; Lariviere, M; N'Dir, O; Py, D; Schulz-Key, H, 1986) |
| "Ocular filariasis was observed in an African student living in Missouri." | 1.27 | Loa loa: ocular filariasis in an African student in Missouri. ( Lee, BY; McMillian, R, 1984) |
| "The pathogenesis and treatment of onchocerciasis are discussed." | 1.27 | Ocular onchocerciasis with living microfilariae in the anterior chamber in two Dutch boys. ( Koppert, HC, 1983) |
| "Diethylcarbamazine was given as eye drops in varying concentrations in a half-log dilution series from 1." | 1.26 | Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery. ( Anderson, J; Fuglsang, H; Jones, BR, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (94.34) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (3.77) | 29.6817 |
| 2010's | 1 (1.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senanayake, MP | 1 |
| Infaq, ML | 1 |
| Adikaram, SG | 1 |
| Udagama, PV | 1 |
| Uhlig, CE | 1 |
| Dietrich, M | 1 |
| Busse, H | 1 |
| MAZZOTTI, L | 1 |
| TORROELLA, J | 1 |
| Terranova, M | 1 |
| Padovese, V | 1 |
| Klaus, S | 1 |
| Morrone, A | 1 |
| Donnelly, JJ | 2 |
| Rockey, JH | 2 |
| Bianco, AE | 1 |
| Soulsby, EJ | 1 |
| Gentilini, M | 1 |
| Carme, B | 1 |
| Giovannini, A | 1 |
| Volanti, S | 1 |
| Chillemi, P | 1 |
| Lee, BY | 1 |
| McMillian, R | 1 |
| Stilma, JS | 1 |
| Ebley, DM | 1 |
| Coker, SM | 1 |
| Koppert, HC | 1 |
| Rozenman, D | 1 |
| Kremer, M | 1 |
| Zuckerman, F | 1 |
| Thylefors, B | 5 |
| Greene, BM | 5 |
| Taylor, HR | 6 |
| Brown, EJ | 1 |
| Humphrey, RL | 1 |
| Lawley, TJ | 1 |
| Schmidt, GM | 1 |
| Krehbiel, JD | 1 |
| Coley, SC | 1 |
| Leid, RW | 1 |
| Rolland, A | 2 |
| Bird, AC | 2 |
| el-Sheikh, H | 1 |
| Anderson, J | 7 |
| Fuglsang, H | 7 |
| Grüntzig, J | 2 |
| Merz, M | 1 |
| Renard, G | 1 |
| Gewalt, W | 1 |
| Vingtain, P | 2 |
| Lucot, J | 1 |
| Chovet, M | 1 |
| Dissanaike, AS | 1 |
| Ramalingam, S | 1 |
| Fong, A | 1 |
| Pathmayokan, S | 1 |
| Thomas, V | 1 |
| Kan, SP | 1 |
| Sprent, JF | 1 |
| Jones, HI | 1 |
| Jones, BR | 2 |
| de C Marshall, TF | 1 |
| Lariviere, M | 2 |
| Aziz, M | 1 |
| Beauvais, B | 1 |
| Weimann, D | 1 |
| Derouin, F | 1 |
| Ginoux, J | 1 |
| Schulz-Key, H | 4 |
| Gaxotte, P | 2 |
| Basset, D | 1 |
| Albiez, EJ | 1 |
| Newland, HS | 3 |
| White, AT | 3 |
| Kaiser, A | 1 |
| Büttner, DW | 1 |
| Diallo, S | 1 |
| Aziz, MA | 4 |
| Diallo, JS | 1 |
| Diop-Mar, I | 1 |
| N'Dir, O | 1 |
| Badiane, S | 1 |
| Py, D | 1 |
| Toufic, N | 2 |
| Murphy, RP | 2 |
| D'Anna, SA | 2 |
| Keyvan-Larijani, E | 1 |
| Cupp, EW | 2 |
| Dadzie, KY | 1 |
| Awadzi, K | 1 |
| Gilles, HM | 1 |
| Duke, BO | 1 |
| Goldschmidt, LP | 1 |
| Young, E | 1 |
| Khatami, M | 1 |
| Lok, JB | 1 |
| Langham, ME | 1 |
| Beltranena, F | 1 |
| Johnson, GJ | 1 |
| Axsmith, K | 1 |
| Desser, SS | 1 |
| Cello, RM | 1 |
| Scheie, HG | 1 |
| Shannon, RE | 1 |
| Yanoff, M | 1 |
| Lazar, M | 2 |
| Lieberman, TW | 1 |
| Leopold, IH | 2 |
| Ben-Sira, I | 1 |
| Aviel, E | 1 |
| Liebermann, TW | 1 |
| Tham, MH | 1 |
| Hall, IB | 1 |
| Gornig, H | 1 |
| Valvo, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis[NCT04188301] | Phase 2 | 154 participants (Actual) | Interventional | 2019-12-06 | Completed | ||
| Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis[NCT06070116] | Phase 2 | 300 participants (Anticipated) | Interventional | 2024-01-15 | Not yet recruiting | ||
| Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis[NCT03517462] | 231 participants (Actual) | Interventional | 2018-08-06 | Completed | |||
| Effect of Albendazole Dose and Interval on Brugia Malayi Microfilarial Clearance in India: A Randomized, Open Label Study[NCT00511004] | Phase 2 | 40 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The effectiveness of three treatment regimens for killing adult female O. volvulus worms based on the percentage of all adult female worms in nodules that are alive 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment
| Intervention | Female worms in nodule (Count of Units) |
|---|---|
| IVM + ALB | 127 |
| IDA x 1 Dose | 142 |
| IDA x 3 Doses | 159 |
The effect of three treatment regimens for killing adult female O. volvulus worms will be compared based on the percentage of all adult female worms in nodules that are alive with embryos in the uterus 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.
| Intervention | Female worms in nodules (Count of Units) |
|---|---|
| IVM + ALB | 127 |
| IDA x 1 Dose | 142 |
| IDA x 3 Doses | 159 |
The effect of three treatment regimens for sterilizing adult female O. volvulus worms will be compared based on the percentage of all adult female worms that are fertile in the nodules 18 months after treatment. (NCT04188301)
Timeframe: 18 months following treatment.
| Intervention | Female worms with intact uterus (Count of Units) |
|---|---|
| IVM + ALB | 41 |
| IDA x 1 Dose | 40 |
| IDA x 3 Doses | 34 |
Rates of ocular adverse events of any grade within 3 months will be compared by treatment group. (NCT04188301)
Timeframe: within 3 months of treatment with IDA
| Intervention | Participants (Count of Participants) |
|---|---|
| IVM + ALB | 4 |
| IDA x 1 Dose | 4 |
| IDA x 3 Doses | 3 |
Rates of adverse events grade 3 or higher that occur within 7 days of treatment in the subset of participants who have intraocular microfilariae just prior to treatment with IDA will be compared by treatment group. (NCT04188301)
Timeframe: within 7 days following end of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| IVM + ALB | 0 |
| IDA x 1 Dose | 0 |
| IDA x 3 Doses | 0 |
Rates of severe adverse events (grade 3 or higher) following 1-day or 3-day triple drug treatment will be compared against those of the comparator regimen of 1 day of IVM/ALB. (NCT04188301)
Timeframe: Within 7 days following end of treatment
| Intervention | Participants (Count of Participants) |
|---|---|
| IVM + ALB | 0 |
| IDA x 1 Dose | 0 |
| IDA x 3 Doses | 0 |
The effectiveness of three treatment regimens for preventing reappearance of microfilariae in the skin as determined by skin snips at 12 and 18 months after treatment will be compared by treatment arm. Measured by the presence of microfilariae in skin snips. (NCT04188301)
Timeframe: Baseline, 12 months, and 18 months following treatment
| Intervention | Count of microfilarae+ participants (Number) | ||
|---|---|---|---|
| Baseline | Month 12 | Month 18 | |
| IDA x 1 Dose | 6 | 21 | 15 |
| IDA x 3 Doses | 0 | 21 | 17 |
| IVM + ALB | 7 | 23 | 20 |
The effectiveness of three treatment regimens for complete clearance of microfilariae from the skin as determined by skin snips at 3, 12, and 18 months after treatment with IDA will be compared by treatment arm. (NCT04188301)
Timeframe: Baseline, 3 months, 12 months, & 18 months following treatment.
| Intervention | Count of Skin Microfilaria (Geometric Mean) | |||
|---|---|---|---|---|
| Baseline | Month 3 | Month 12 | Month 18 | |
| IDA x 1 Dose | 1.7 | 3 | 2.5 | 9.0 |
| IDA x 3 Doses | NA | 2.1 | 4.7 | 8.6 |
| IVM + ALB | 3.1 | 1.9 | 4.9 | 7.0 |
Doppler detected worm nests at 2 years (NCT00511004)
Timeframe: 2 years from the time enrolled.
| Intervention | Number of nests (Median) |
|---|---|
| Standard Therapy Annual DEC/ALB | 0 |
| High Dose Annual DEC/ALB | 0 |
| High Dose Semiannual DEC/ALB | 0 |
IgG4 antibodies directed against Brugia malayi antigen (NCT00511004)
Timeframe: 2 years
| Intervention | ng/ml (Median) |
|---|---|
| Standard Therapy Annual DEC/ALB | 150 |
| High Dose Annual DEC/ALB | 224 |
| High Dose Semiannual DEC/ALB | 128 |
Night time microfilarial counts at 1 year (NCT00511004)
Timeframe: 1 year from time enrolled
| Intervention | MF/ML (Median) |
|---|---|
| Standard Therapy Annual DEC/ALB | 0 |
| High Dose Annual DEC/ALB | 0 |
| High Dose Semiannual DEC/ALB | 0 |
Night time microfilarial levels at 2 years (NCT00511004)
Timeframe: 2 years from time enrolled
| Intervention | MF/ML (Median) |
|---|---|
| Diethylcarbamazine/Albendazole -STD | 0 |
| Diethylcarbamazine/Albendazole- HD1 | 0 |
| Diethylcarbamazine/Albendazole-HD2 | 0 |
2 reviews available for diethylcarbamazine and Eye Disorders
| Article | Year |
|---|---|
Ocular onchocerciasis.
Topics: Diethylcarbamazine; Eye; Eye Diseases; Female; Glaucoma; Humans; Iritis; Keratitis; Male; Onchocerci | 1977 |
Ocular onchocerciasis in the horse.
Topics: Animals; Anterior Chamber; Austria; California; Cataract; Ciliary Body; Conjunctivitis; Diethylcarba | 1971 |
9 trials available for diethylcarbamazine and Eye Disorders
| Article | Year |
|---|---|
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular and systemic complications of diethylcarbamazine therapy for onchocerciasis: association with circulating immune complexes.
Topics: Antigen-Antibody Complex; Complement System Proteins; Diethylcarbamazine; Eye Diseases; Humans; Immu | 1983 |
Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.
Topics: Administration, Oral; Administration, Topical; Adult; Clinical Trials as Topic; Diethylcarbamazine; | 1981 |
Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.
Topics: Adolescent; Adult; Aged; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind M | 1985 |
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
Topics: Adult; Animals; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-B | 1988 |
A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye Diseases; | 1986 |
Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye; Eye Di | 1986 |
Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye; Eye Di | 1986 |
Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye; Eye Di | 1986 |
Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
Topics: Adult; Anthelmintics; Clinical Trials as Topic; Diethylcarbamazine; Double-Blind Method; Eye; Eye Di | 1986 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Clinical Trials as Topic; Cornea; Diethylcarbamazine; Double-Bl | 1987 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
Topics: Adult; Anthelmintics; Antiparasitic Agents; Clinical Trials as Topic; Cornea; Corneal Opacity; Dieth | 1985 |
Topical diethylcarbamazine in ocular onchocerciasis.
Topics: Administration, Topical; Adult; Anterior Chamber; Cameroon; Cornea; Diethylcarbamazine; Edema; Eye D | 1973 |
42 other studies available for diethylcarbamazine and Eye Disorders
| Article | Year |
|---|---|
Ocular and subcutaneous dirofilariasis in a Sri Lankan infant: an environmental hazard caused by dogs and mosquitoes.
Topics: Animals; Diethylcarbamazine; Dirofilaria repens; Dirofilariasis; Eye Diseases; Filaricides; Humans; | 2013 |
[Asthenoscopic problems with a subconjunctival worm].
Topics: Adult; Asthenopia; Diethylcarbamazine; Emergencies; Eye Diseases; Filaricides; Humans; Loiasis; Male | 2002 |
[Hetrazan negative results in two human cases of ocular cysticercosis].
Topics: Cysticercosis; Diethylcarbamazine; Eye; Eye Diseases; Head; Humans | 1955 |
Onchocerciasis in Tigray.
Topics: Adult; Aged; Animals; Child; Diethylcarbamazine; Doxycycline; Eosinophilia; Ethiopia; Eye Diseases; | 2007 |
Aqueous humor and serum IgE antibody in experimental ocular Onchocerca infection of guinea pigs.
Topics: Animals; Aqueous Humor; Diethylcarbamazine; Disease Models, Animal; Eye Diseases; Guinea Pigs; Immun | 1983 |
[Treatment of filariases in a hospital setting. Complications - results].
Topics: Diethylcarbamazine; Dracunculiasis; Eye Diseases; Filariasis; Humans; Loiasis; Lymphatic Diseases | 1981 |
[A clinical case of ocular onchocerciasis: clinical, angiofluorographic and developmental aspects].
Topics: Adult; Chorioretinitis; Choroid; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; | 1984 |
Loa loa: ocular filariasis in an African student in Missouri.
Topics: Adult; Cameroon; Diethylcarbamazine; Eye Diseases; Filariasis; Humans; Loiasis; Male; Missouri | 1984 |
Eye screening in 2234 Sierra Leonean school students and detection of onchocerciasis.
Topics: Adolescent; Child; Diethylcarbamazine; Eye Diseases; Female; Humans; Male; Mass Screening; Onchocerc | 1983 |
Ocular onchocerciasis with living microfilariae in the anterior chamber in two Dutch boys.
Topics: Adolescent; Anterior Chamber; Cameroon; Child; Child, Preschool; Diethylcarbamazine; Eye Diseases; H | 1983 |
Onchocerciasis in Israel.
Topics: Adolescent; Diagnosis, Differential; Diethylcarbamazine; Ethiopia; Eye Diseases; Humans; Israel; Mal | 1984 |
[Ocular oncocerciasis and its treatment].
Topics: Adolescent; Adult; Child; Child, Preschool; Diethylcarbamazine; Eye Diseases; Female; Humans; Male; | 1984 |
Equine ocular onchocerciasis: histopathologic study.
Topics: Age Factors; Animals; Diethylcarbamazine; Disease Models, Animal; Eye Diseases; Horse Diseases; Hors | 1982 |
Basis for treatment and prevention of ocular onchocerciasis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Diethylcarbamazine; Drug Therap | 1982 |
[Basis of the treatment and prevention of ocular onchocerciasis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Africa; Antinematodal Agents; Diethylcarbamazine; Drug T | 1982 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Topics: Adolescent; Adult; Child; Diethylcarbamazine; Eye Diseases; Fluorescein Angiography; Humans; Male; M | 1980 |
[River blindness, infection by the filaria Onchocerca volvulus].
Topics: Africa; Bone Diseases; Central America; Dermatitis; Diethylcarbamazine; Disease Outbreaks; Eye Disea | 1980 |
[Onchocercosis: A disease full of puzzles (author's transl)].
Topics: Diethylcarbamazine; Eye Diseases; Humans; Onchocerca; Onchocerciasis | 1980 |
[Ocular manifestations of loaiasis].
Topics: Diethylcarbamazine; Eye Diseases; Eye Manifestations; Filariasis; Humans; Loiasis; Retinal Diseases; | 1978 |
[Cameroon swelling; infection by the filaria Loa loa].
Topics: Cameroon; Diethylcarbamazine; Edema; Eosinophilia; Eye Diseases; Filariasis; Humans; Insect Vectors; | 1979 |
Ocular onchocerciasis.
Topics: Diethylcarbamazine; Drug Therapy, Combination; Eye Diseases; Humans; Insect Control; Onchocerciasis; | 1978 |
[Therapy of ocular onchocerciasis].
Topics: Anthelmintics; Diethylcarbamazine; Eye Diseases; Filaricides; Humans; Keratitis; Onchocerciasis; Sur | 1979 |
Filaria in the vitreous of the eye of man in peninsular Malaysia.
Topics: Diethylcarbamazine; Dirofilaria immitis; Dirofilariasis; Eye Diseases; Female; Humans; Malaysia; Mid | 1977 |
Toxocariasis.
Topics: Animals; Ascariasis; Cats; Child; Diethylcarbamazine; Dogs; Eye Diseases; Humans; Infant; Larva Migr | 1977 |
Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.
Topics: Adult; Child; Cornea; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Administration Sche | 1978 |
Further observations on the relationship between ocular onchocerciasis and the head nodule, and on the possible benefit of nodulectomy.
Topics: Cameroon; Dermatologic Surgical Procedures; Diethylcarbamazine; Eye; Eye Diseases; Female; Head; Hum | 1978 |
Further observations on the relationship between ocular onchocerciasis and the head nodule, and on the possible benefit of nodulectomy.
Topics: Cameroon; Dermatologic Surgical Procedures; Diethylcarbamazine; Eye; Eye Diseases; Female; Head; Hum | 1978 |
Further observations on the relationship between ocular onchocerciasis and the head nodule, and on the possible benefit of nodulectomy.
Topics: Cameroon; Dermatologic Surgical Procedures; Diethylcarbamazine; Eye; Eye Diseases; Female; Head; Hum | 1978 |
Further observations on the relationship between ocular onchocerciasis and the head nodule, and on the possible benefit of nodulectomy.
Topics: Cameroon; Dermatologic Surgical Procedures; Diethylcarbamazine; Eye; Eye Diseases; Female; Head; Hum | 1978 |
Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.
Topics: Adolescent; Adult; Betamethasone; Child; Diethylcarbamazine; Drug Therapy, Combination; Eye Diseases | 1978 |
Effects of diethylcarbamazine on ocular onchocerciasis.
Topics: Adolescent; Adult; Anterior Chamber; Child; Cornea; Diethylcarbamazine; Eye Diseases; Female; Fundus | 1976 |
[Loaiasis and its therapeutic difficulties].
Topics: Diethylcarbamazine; Eye Diseases; Filariasis; Humans; Ivermectin; Loiasis | 1986 |
Need for caution in use of DEC for treatment of onchocerciasis.
Topics: Diethylcarbamazine; Eye Diseases; Humans; Onchocerciasis | 1986 |
Experimental ocular onchocerciasis in cynomolgus monkeys.
Topics: Animals; Anterior Chamber; Diethylcarbamazine; Disease Models, Animal; Eye; Eye Diseases; Macaca fas | 1986 |
The Onchocerca volvulus micro- and macrofilarial responses in onchocerciasis patients to increased dosage of diethylcarbamazine.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anterior Chamber; Cornea; Diethylcarb | 1985 |
Toxocara.
Topics: Animals; Cats; Diethylcarbamazine; Dog Diseases; Dogs; Eye Diseases; Humans; Nematode Infections; Pa | 1972 |
[The therapeutic difficulties of ocular onchocerciasis].
Topics: Arsenicals; Diethylcarbamazine; Eye Diseases; Humans; Onchocerciasis; Optic Nerve; Suramin; Thiabend | 1969 |
Inflammatory pseudotumours of the orbit: a probable case of microfilarial granuloma of the orbit.
Topics: Adult; Dermoid Cyst; Diagnosis, Differential; Diethylcarbamazine; Exophthalmos; Eye Diseases; Filari | 1970 |
The elusive Loa loa. A case report of ocular filariasis in Canada.
Topics: Adult; Canada; Diethylcarbamazine; Eye Diseases; Female; Filariasis; Humans; Liberia; Loa | 1973 |
Onchocerciasis (ocular).
Topics: Biopsy; Child; Diagnosis, Differential; Diethylcarbamazine; Diphenhydramine; Eye Diseases; Female; H | 1971 |
Topical diethylcarbamazine in the treatment of ocular onchocerciasis.
Topics: Absorption; Animals; Diethylcarbamazine; Eye Diseases; Onchocerciasis; Ophthalmic Solutions; Rabbits | 1970 |
Topical hetrazan in the treatment of ocular onchocerciasis.
Topics: Adult; Blindness; Conjunctiva; Diethylcarbamazine; Eye Diseases; Humans; Onchocerca; Onchocerciasis | 1970 |
Impacted microfilaria in the lens capsule.
Topics: Adult; Atropine; Diethylcarbamazine; Eye Diseases; Filariasis; Humans; Lens, Crystalline; Male | 1971 |
[Eye involvement in onchocerciasis].
Topics: Adult; Biopsy; Complement Fixation Tests; Cornea; Diagnosis, Differential; Diethylcarbamazine; Eye D | 1967 |
[Ocular filariasis caused by Loa-loa: new clinico-therapeutic acquistitions].
Topics: Adult; Arsenicals; Diethylcarbamazine; Eye Diseases; Female; Filariasis; Humans; Loa | 1968 |